A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan wins 1st gold at World University Games in women's team poomsae
07/18/2025 08:53 PM - Sports
Corbin Carroll eyes USA's WBC team, but two others may be in on Taiwan
07/18/2025 08:20 PM - Business
Asia-Pacific telecom giants launch submarine cable to boost connectivity
07/18/2025 07:22 PM - Politics
5 more KMT lawmakers to face recall votes on Aug. 23: CEC
07/18/2025 07:08 PM - Politics
Defense chief lauds effort but acknowledges mishaps in Taiwan drills
07/18/2025 06:45 PM